- Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma
-
Febro RJD, Perillo ESS, Kimura AA, Wong SN
- KMID: 2559470
- J Liver Cancer.
- 2024 Sep;24(2):234-242.
- doi: 10.17998/jlc.2024.05.23
Backgrounds/Aims: Atezolizumab/bevacizumab is the recommended first-line systemic therapy for unresectable hepatocellular carcinoma (uHCC) and may facilitate curative conversion through resection and locoregional therapies. However, there have been very few reports... -
- CITED
-
- Close
- SHARE
-
- Close
